SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-005561
Filing Date
2022-02-07
Accepted
2022-02-04 18:52:51
Documents
15
Period of Report
2022-02-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154982-8k_edocacquis.htm   iXBRL 8-K 44345
2 PRESS RELEASE OF CALIDI BIOTHERAPEUTICS, INC, DATED FEBRUARY 4, 2022. ea154982ex99-1_edocacq.htm EX-99.1 18472
7 GRAPHIC image_001.jpg GRAPHIC 4288
  Complete submission text file 0001213900-22-005561.txt   308552

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adoc-20220204.xsd EX-101.SCH 4196
4 XBRL DEFINITION FILE adoc-20220204_def.xml EX-101.DEF 27563
5 XBRL LABEL FILE adoc-20220204_lab.xml EX-101.LAB 38109
6 XBRL PRESENTATION FILE adoc-20220204_pre.xml EX-101.PRE 26181
9 EXTRACTED XBRL INSTANCE DOCUMENT ea154982-8k_edocacquis_htm.xml XML 7150
Mailing Address 7612 MAIN STREET FISHERS SUITE 200 VICTOR NY 14564
Business Address 7612 MAIN STREET FISHERS SUITE 200 VICTOR NY 14564 5856781198
Edoc Acquisition Corp. (Filer) CIK: 0001824884 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39689 | Film No.: 22595088
SIC: 6770 Blank Checks